Global Pelvic Floor Electrical Stimulation Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Pelvic Floor Electrical Stimulation Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Electrical stimulation of pelvic floor is a painless and effective method to treat urinary incontinence, frequent micturition and urgency. Pelvic floor electrical stimulation devices are usually used for patients with frequent urination, urgency or urinary incontinence due to overactive bladder. It is also used to help women with weak vaginal muscle tension strengthen the pelvic floor. In the process of pelvic floor electrical stimulation, low-grade electrical current stimulates muscle contraction, and produces muscle response similar to Kegels (pelvic floor muscle exercise). This exercise can strengthen pelvic floor muscles, thus improving frequent urination, urgency and urinary incontinence, and increasing the strength of pelvic floor and vaginal muscles.

Market Overview:


The latest research study on the global Pelvic Floor Electrical Stimulation Devices market finds that the global Pelvic Floor Electrical Stimulation Devices market reached a value of USD 146.38 million in 2022. It’s expected that the market will achieve USD 253.1 million by 2028, exhibiting a CAGR of 9.56% during the forecast period.

Market Trends


According to the product type, the pelvic floor electrical stimulation equipment market covers fixed and mobile. Among them, mobile pelvic floor electrical stimulation devices have quickly become the first choice for healthcare professionals and patients. Compared with fixed equipment or surgical treatment, mobile equipment has lower cost, higher portability, positive treatment effect and positive therapeutic outcomes coupled with easy access to patients through over-the-counter medical channels for use in home care settings, which is expected to support the growth of this market segment in the foreseeable future.

Opportunities

Atlantic Therapeutics has established INNOVO brand as a leading innovation in the field of non-invasive and wearable neuromuscular electrical stimulation. The device is used to strengthen the pelvic floor, so as to treat the potential causes of bladder weakness. INNOVO is a CE marker therapy approved by the US Food and Drug Administration to treat female stress urinary incontinence. It provides clinically proven, safe and non-invasive pelvic floor stimulation through unique wearable technology. At home, women can simply put on a pair of shorts and do pelvic floor exercises for 30 minutes. INNOVO shorts embedded in innovative NMES (neuromuscular electrical stimulation) technology can strengthen and re-educate women's pelvic floor muscles, giving women a chance to improve within three months. The development of new technologies and the emergence of new products will bring new development opportunities to the Pelvic Floor Electrical Stimulation Devices industry, thus promoting the development of the industry.

Drivers

The increasing incidence of urinary incontinence
Urinary incontinence, also known as bladder weakness, is a stigmatized disease, which affects one third of women in the world and has a far-reaching negative impact on the quality of life and enjoyment. And its incidence increases with age. Urinary incontinence is caused by urinary tract infection, weakening of pelvic floor muscles and urethral sphincter, menopause, pregnancy and childbirth. The increasing incidence of urinary incontinence will drive the demand for Pelvic Floor Electrical Stimulation Devices.

Region Overview:


From 2022-2027, North America is estimated to witness robust growth prospects.

Company Overview:


Laborie, Inc. is one of the major players operating in the Pelvic Floor Electrical Stimulation Devices market, holding a share of 8.89% in 2021.

LABORIE is a leading global developer, manufacturer and marketer of innovative medical technology and consumables used for the diagnosis and treatment of pelvic health in the Urology, Gynecology, and Colorectal fields as well as gastrointestinal procedures. With its recent acquisition of Clinical Innovations, LABORIE is a leader in medical devices developed for labor and delivery and neonatal intensive care. LABORIE is a portfolio company of Patricia Industries.

Since 1996, Zynex Medical has been a leading provider of relief for patients with functional disabilities through the creation, distribution, and marketing of the highest-quality electrotherapy products available today. Zynex Medical continually strives to uphold its mission to improve the quality of life for patients suffering from debilitating pain or illness by providing the highest technology and service standards in the electrotherapy industry.

Segmentation Overview:


Among different product types, Mobile segment is anticipated to contribute the largest market share in 2027.

Application Overview:


By application, the Home Care Settings segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Pelvic Floor Electrical Stimulation Devices market covered in Chapter 3:

Utah Medical Products, Inc.
Atlantic Therapeutics
Zynex Medical
InControl Medical Limited
Shenzhen XFT Medical Limited
Verity Medical Ltd
Tic Medizintechnik GmbH
KayCo 2 Ltd.
Laborie, Inc.
TensCare Ltd.
The Prometheus Group

In Chapter 4 and Chapter 14.2, on the basis of types, the Pelvic Floor Electrical Stimulation Devices market from 2018 to 2029 is primarily split into:

Mobile
Fixed

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Pelvic Floor Electrical Stimulation Devices market from 2018 to 2029 covers:

Hospitals
Clinics
Home Care Settings
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)